Inlive (Enterovirus Type 71 Vaccine , Inactivated )

Inlive (Enterovirus Type 71 Vaccine , Inactivated )
Product Description


Inlive is an original preventive vaccine in the world, independently developed by Sinovac Biotech Ltd., which is mainly used to prevent the Hand-Foot-Month Disease(HFMD) caused by Enterovirus Type 71(EV71) under 3 years old. The research of EV71 vaccine was initiated in May, 2008.Through close collaborations with China Food and Drug Administration (CFDA), Centers for Disease Control and Prevention (CDCs) and well-known research institutions, it costed us 8 years with extensive capital investment to complete the pre-clinical research, clinical trials (Phase I - Phase III), and commercial plant. In December 2015, Inlive was approved to be commercialized in China.         

Sinovac biotech (Hong Kong) Limited

  • HK
  • 2018
    On CPHI since
Specifications

Sinovac biotech (Hong Kong) Limited

  • HK
  • 2018
    On CPHI since

More Products from Sinovac biotech (Hong Kong) Limited (2)

  • Healive (Hepatitis A Vaccine, Inactivated)

    Product Healive (Hepatitis A Vaccine, Inactivated)

    Healive is the first inactivated hepatitis A vaccine developed in China by Chinese scientists who retained the intellectual property rights. It brought to an end an era in which China did not have its own technology for developing and producing inactivated Hepatitis A vaccine. Healive received the new drug ce...
  • Anflu (Influenza Vaccine , Inactivated)

    Product Anflu (Influenza Vaccine , Inactivated)

    Sinovac commenced the development of its split influenza vaccine in 2001. The pre-clinical research was completed in 2004. The result of clinical trial for Anflu showed that it is well tolerated in children, adults and the elderly. In June 2006, Sinovac submitted the New Drug application to China State Food a...

Sinovac biotech (Hong Kong) Limited resources (2)

  • News Sinovac Biotech signs up to supply COVAX with CoronaVac

    China-based company could supply up to 380 million doses from July 2021 through to June 2022
  • Brochure Sinovac-Profile & Main Products

    Sinovac  Biotech Co., Ltd. is a China-based biopharmaceutical company that aiming to provide Chinese children with international quality vaccine and provide Children in the world with vaccines made in China.

    To achieve these objectives, Sinovac focuses research, development, manufacture and commercialization of vaccines for infectious diseases with significant unmet medical need. 

    Sinovac also provides services for diseases control and prevention, collaborating with the Chinese governments at the national, state and county levels.

    Main products are Haelive(Hepatitis A vaccine),Inlive(Hand-Foot-Mouth Disease vaccine),Anful (Influenza vaccine)etc. The products have been sold to over 30 countries and regions in the world.